Multidisciplinary Journal of Science and Technology

Clinical functional and genetic predictors of ischemic heart disease in the context of obesity

O.G. Tilepbaeva

Tashkent Medical Academy

S.K.Nuritdinova

Tashkent Medical Academy

Keywords: obesity, coronary heart disease, insulin resistance

---

Abstract

Obesity has emerged as a significant risk factor for ischemic heart disease (IHD), particularly in western countries where the availability of energy-dense processed foods has led to increased prevalence rates. This rise in obesity prevalence in diverse populations highlights the importance of understanding clinical, functional, and genetic predictors of IHD in the context of excess adiposity. While traditional health risks associated with obesity, such as type 2 diabetes and hypertension, are well-recognized, emerging research indicates that factors like fat distribution, metabolic profiles, and genetic predispositions play crucial roles in determining individual risk for IHD.

The relationship between obesity and cardiovascular health is complex; studies show that visceral fat, as indicated by waist circumference, is a better predictor of cardiovascular risk than body mass index (BMI) alone. Additionally, recent findings suggest that insulin resistance is critically linked to both obesity and the development of IHD, with variations in individual responses to weight and fat distribution further complicating risk assessment.

Research exploring the genetic underpinnings of obesity-related IHD is expanding, revealing various susceptibility loci that may influence disease progression in different populations. Notably, the interaction between lifestyle factors—such as physical activity—and genetic predispositions can shape the trajectory of IHD risk among individuals with obesity.

Furthermore, recent studies underscore the importance of holistic approaches combining clinical assessments, metabolic profiling, and genetic screening for accurately identifying individuals at high risk for IHD. Despite advancements in treatment options, including statin therapy, the efficacy of these interventions in obese populations presents ongoing challenges, necessitating further research to optimize management strategies and improve patient outcomes. Understanding these complex interrelations can lead to better prevention and therapeutic measures for ischemic heart disease that consider individual patient profiles within the context of obesity.

---

References

1. Walley A.J., Blakemore A.I.F., Froguel P. Genetics of Obesity and the Prediction of Risk for Health // 2006. – P. 124-130 [1].

2. Powell-Wiley T.M., Poirier P., Burke L.E., Després J.-P., Gordon-Larsen P., Lavie C.J., Lear S.A., Ndumele C.E., Neeland I.J., Sanders P. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association // Circulation. – 2021. – P. 985 [2].

3. Abbasi F., Brown B.W. Jr, Lamendola C., McLaughlin T., Reaven G.M. Relationship Between Obesity, Insulin Resistance, and Coronary Heart Disease Risk //2002. – P. 940 [3].

4. Piché M.-E., Tchernof A., Després J.-P. Obesity Phenotypes, Diabetes, and Cardiovascular Diseases // 2020. – P. 1477 [4].

5. Li T.Y., Rana J.S., Manson J.E., Willett W.C., Stampfer M.J., Colditz G.A., Rexrode K.M., Hu F.B. Obesity as Compared With Physical Activity in Predicting Risk of Coronary Heart Disease in Women // 2005. – P. 499-500 [5].

6. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of Coronary Heart Disease Using Risk Factor Categories //2004. – P. 1837 [6].

7. Larifla L., Beaney K.E., Foucan L., Bangou J., Michel C.T., Martino J., Velayoudom-Cephise F.-L., Cooper J.A., Humphries S.E. Influence of Genetic Risk Factors on Coronary Heart Disease Occurrence in Afro-Caribbeans // 2016. – P. 978 [7].

8. Horwich T.B., MacLellan W.R., Fonarow G.C. Statin Therapy Is Associated With Improved Survival in Ischemic and Non-Ischemic Heart Failure //2004. – P. 642 [8]